Search

everythinglearnresearchcommunity

for

Search:↓

UVB is good for a skin condition in Asian kids, a lotion works for head lice, a drug helps with a skin blistering disorder, a foam reduces itchiness in skin inflammation, birthmarks can be more widespread, and criteria for a neurocutaneous disorder were agreed upon.

New vitiligo treatments focus on controlling immune damage and restoring skin color.

Skin cancer is common in elderly nursing home residents, with risk factors including being male, having light skin, outdoor work history, and smoking. Regular skin checks are recommended.

The X5 Hairlaser might help treat male hair loss, but more research is needed.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

Repigmentation in vitiligo may come from melanocyte stem cells in the skin.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Many treatments for alopecia areata have inconsistent results; for under 10s, use minoxidil with a corticosteroid, and for over 10s, add ILC and consider diphenylcyclopropenone for widespread cases.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Fractional lasers seem effective and safe for treating hair loss, but more research is needed to find the best treatment methods.

The study found that the most common repigmentation pattern in children with vitiligo is a combination of patterns, with a new medium spotted pattern identified.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Dermoscopy is useful for tracking alopecia areata treatment, with yellow dots and new vellus hairs being good indicators of hair regrowth.

No treatment alters the natural progression of alopecia areata, and effectiveness varies, with some possibly working better in children.

Lasers might help hair growth in some alopecia cases, but more research is needed to confirm their effectiveness and safety.

New treatments focusing on immune pathways show promise for stubborn hair loss.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

A combination of oral cyclosporin and PUVA treatment worked well for a severe skin condition called generalized pustular psoriasis.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Green tea may help with various skin conditions and protect the skin when taken orally or applied topically, but its effectiveness is not always proven.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.